NADROPARIN for Atrial fibrillation: Side Effects & Safety Data

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

There are 12 adverse event reports in the FDA FAERS database where NADROPARIN was used for Atrial fibrillation.

Most Reported Side Effects for NADROPARIN

Side Effect	Reports	%	Deaths	Hosp.
Foetal exposure during pregnancy	81	12.0%	5	21
Off label use	77	11.4%	17	44
Premature baby	73	10.8%	3	30
Maternal exposure during pregnancy	72	10.7%	1	25
Drug ineffective	54	8.0%	3	25
Sepsis	46	6.8%	0	45
Dyspnoea	44	6.5%	2	29
Fall	43	6.4%	0	42
Exposure during pregnancy	42	6.2%	0	5
Confusional state	40	5.9%	19	26
Diarrhoea	34	5.0%	0	27
Hypertension	34	5.0%	19	19
Premature delivery	34	5.0%	0	7
Thrombocytopenia	33	4.9%	4	28
Platelet count decreased	32	4.7%	0	30